Idorsia Ltd. (IDRSF)
7.25
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Idorsia Shareholders Equity (Quarterly) : -1.480B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.480B |
| March 31, 2026 | -1.464B |
| December 31, 2025 | -1.435B |
| September 30, 2025 | -1.427B |
| June 30, 2025 | -1.434B |
| March 31, 2025 | -1.280B |
| December 31, 2024 | -1.338B |
| September 30, 2024 | -1.126B |
| June 30, 2024 | -1.160B |
| March 31, 2024 | -1.040B |
| December 31, 2023 | -1.151B |
| September 30, 2023 | -908.40M |
| June 30, 2023 | -1.164B |
| March 31, 2023 | -941.66M |
| December 31, 2022 | -714.39M |
| September 30, 2022 | -551.75M |
| June 30, 2022 | -350.96M |
| March 31, 2022 | -131.12M |
| December 31, 2021 | 114.37M |
| Date | Value |
|---|---|
| September 30, 2021 | 243.53M |
| June 30, 2021 | 390.63M |
| March 31, 2021 | 519.46M |
| December 31, 2020 | 662.35M |
| September 30, 2020 | 228.57M |
| June 30, 2020 | 337.96M |
| March 31, 2020 | 59.87M |
| December 31, 2019 | 178.08M |
| September 30, 2019 | 328.18M |
| June 30, 2019 | 454.28M |
| March 31, 2019 | 565.31M |
| December 31, 2018 | 674.26M |
| September 30, 2018 | 794.91M |
| June 30, 2018 | 597.17M |
| March 31, 2018 | 699.71M |
| December 31, 2017 | 764.95M |
| September 30, 2017 | 703.34M |
| June 30, 2017 | 781.60M |
| March 31, 2017 | 405.22M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 5.174B |
| AC Immune SA | 43.60M |
| CRISPR Therapeutics AG | 1.747B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 575.13M |
| Total Liabilities (Quarterly) | 2.055B |
| Debt to Equity Ratio | -1.124 |
| Current Ratio | 0.5819 |
| Net Debt Paydown Yield | -2.55% |